Elevated plasma endothelin-1 levels in diabetes mellitus.
暂无分享,去创建一个
J. Schneider | U. Sommer | A. Hamann | K. Dugi | T. Hierl | G. Leidig-Bruckner | C. Kasperk | N. Tilly | G. Leidig‐Bruckner
[1] B. Žižek,et al. Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension , 2001, Heart.
[2] J. R. Mcneill,et al. Plasma endothelin levels and vascular responses at different temporal stages of streptozotocin diabetes. , 1999, European journal of pharmacology.
[3] G. D. Johnston,et al. Endothelial function in offspring of Type 1 diabetic patients with and without diabetic nephropathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[4] Philip D. Harvey,et al. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.
[5] C. Ferri,et al. Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy. , 1998, American journal of hypertension.
[6] B. Tarquini,et al. Influence of non-insulin-dependent diabetes mellitus on plasma endothelin-1 levels in patients with advanced atherosclerosis. , 1998, Journal of diabetes and its complications.
[7] T. Lüscher,et al. Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function. , 1998, Hypertension.
[8] J. Deanfield,et al. Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study. , 1998, Journal of the American College of Cardiology.
[9] H. Krum,et al. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. , 1998, The New England journal of medicine.
[10] T. Lüscher,et al. Angiotensin II Increases Vascular and Renal Endothelin-1 and Functional Endothelin Converting Enzyme Activityin Vivo:Role of ETAReceptors for Endothelin Regulation , 1997 .
[11] E. Schiffrin,et al. Clinical significance of endothelin in cardiovascular disease , 1997, Current opinion in cardiology.
[12] S. Aksöyek,et al. Plasma endothelin‐1 levels in non‐insulin dependent diabetes mellitus patients with macrovascular disease , 1997, Coronary artery disease.
[13] G. Desideri,et al. Effect of ACE Inhibition on Spontaneous and Insulin-Stimulated Endothelin-1 Secretion: In Vitro and In Vivo Studies , 1997, Diabetes.
[14] J. Kastrup,et al. Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril. , 1996, Cardiovascular research.
[15] D. Guédin,et al. Why are circulating concentrations of endothelin-1 so low? , 1994, Cardiovascular research.
[16] C. G. Olthof,et al. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. , 1994, Clinical science.
[17] G. Pinna,et al. Plasma Endothelin in NIDDM Patients With and Without Complications , 1994, Diabetes Care.
[18] H. Teufelsbauer,et al. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. , 1993, The American journal of cardiology.
[19] N. Iwasaki,et al. Increased Plasma Endothelin in NIDDM Patients With Retinopathy , 1992, Diabetes Care.
[20] B. Binder,et al. Polar secretion of endothelin-1 by cultured endothelial cells. , 1992, The Journal of biological chemistry.
[21] J. Leach,et al. Plasma Endothelinlike Immunoreactivity Levels in IDDM Patients with Microalbuminuria , 1992, Diabetes Care.
[22] P. Binkley,et al. Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure , 1992, Circulation.
[23] A. Lerman,et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. , 1991, The New England journal of medicine.
[24] A. Lerman,et al. Endothelin Has Biological Actions at Pathophysiological Concentrations , 1991, Circulation.
[25] E. Schiffrin,et al. Plasma endothelin in human essential hypertension. , 1991, American journal of hypertension.
[26] K. Takahashi,et al. Elevated plasma endothelin in patients with diabetes mellitus , 1990, Diabetologia.
[27] W. Waldhäusl,et al. Effect of endothelin-1 in man. , 1990, Circulation.
[28] K. Nakao,et al. Increased plasma endothelin level in patients with essential hypertension. , 1990, The New England journal of medicine.
[29] M. Yanagisawa,et al. INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTION , 1989, The Lancet.
[30] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[31] T. Lüscher,et al. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. , 1997, Biochemical and biophysical research communications.
[32] C. Ferri,et al. Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition. , 1995, American journal of hypertension.
[33] K. Usadel,et al. Increased plasma levels of endothelin in diabetic patients with hypertension. , 1992, American journal of hypertension.